The efficacy and safety of wedge resection for peripheral stage IA lung adenocarcinoma: a real-world study based on a single center

被引:3
|
作者
Bian, Dongliang [1 ]
Xiong, Yicheng [1 ]
Jin, Kaiqi [1 ]
Zhu, Yuming [1 ]
Yu, Huansha [2 ]
Dai, Jie [1 ]
Jiang, Gening [1 ]
机构
[1] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Dept Thorac Surg, Shanghai, Peoples R China
[2] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Dept Anim Expt Ctr, Shanghai, Peoples R China
基金
国家重点研发计划; 中国国家自然科学基金;
关键词
Lung adenocarcinoma stage IA; wedge resection; recurrence; SECTION COMPUTED-TOMOGRAPHY; LIMITED RESECTION; SUBLOBAR RESECTION; SURVIVAL OUTCOMES; CANCER; LOBECTOMY; IMPACT; CLASSIFICATION;
D O I
10.21037/jtd-22-1010
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: The effectiveness of segmentectomy for stage IA lung adenocarcinoma (IA-LUAD) has been well-documented. However, the efficacy and safety of wedge resection for peripheral IA-LUAD remains controversial. This study evaluated the feasibility of wedge resection in patients with peripheral IA-LUAD. Methods: Patients with peripheral IA- LUAD who underwent wedge resection by video- assisted thoracoscopic surgery (VATS) at Shanghai Pulmonary Hospital were reviewed. Cox proportional hazards modeling was performed to identify predictors of recurrence. Receiver operating characteristic (ROC) curve analysis was used to calculate the optimal cutoffs of identified predictors. Results: A total of 186 patients (female/male, 115/ 71; mean age, 59.9 years) were included. Mean maximum dimension of consolidation component (MCD) was 5.6 mm, consolidation-to-tumor ratio (CTR) was 37%, and mean computed tomography value of tumor (CTVt) was -285.4 HU. With a median follow-up of 67 months (interquartile range, 52-72 months), the 5-year recurrence rate was 4.84%. Ten patients occurred recurrence postoperatively. No recurrence was observed adjacent to the surgical margin. Increasing MCD, CTR, and CTVt were associated with a higher risk of recurrence, with corresponding hazard ratios (HRs) of 1.212 [95% confidence interval (CI): 1.120-1.311], 1.054 (95% CI: 1.018-1.092), and 1.012 (95% CI: 1.004-1.019) with optimal cutoffs for predicting recurrence of 10 mm, 60%, and -220 HU, respectively. When a tumor had characteristics under these respective cutoffs, no recurrence was observed. Conclusions: Wedge resection can be considered to be a safe and efficacious management strategy for patients with peripheral IA-LUAD, especially for MCD less than 10 mm, CTR less than 60% and CTVt less than -220 HU.
引用
收藏
页码:54 / 64
页数:11
相关论文
共 50 条
  • [41] Efficacy and safety of belimumab in lupus nephritis patients: a real-world observational study in China
    Tan, Meng
    Xu, Jing
    Tan, Ying
    Qu, Zhen
    Yu, Feng
    Zhao, Minghui
    KIDNEY DISEASES, 2023, 9 (03) : 218 - 228
  • [42] Comparison of the clinical outcomes of patients with stage IA-IIA2 cervical adenocarcinoma and squamous cell carcinoma after radical hysterectomy: A propensity score-matched real-world analysis
    Liang, Cong
    Su, Guidong
    Sun, Lixin
    Zhao, Hongwei
    Liu, Ping
    Chen, Chunlin
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2024, 166 (01) : 272 - 281
  • [43] Similar overall survivals of wedge resection and segmentectomy in stage IA1 non-small cell lung cancer: a population-based study using propensity score matching and coarsened exact matching
    Zhu, Lianxin
    Lei, Jinsong
    Yang, Han
    Huang, Long
    JOURNAL OF THORACIC DISEASE, 2024, 16 (12)
  • [44] Molecular mechanism of the treatment of lung adenocarcinoma by Hedyotis Diffusa: an integrative study with real-world clinical data and experimental validation
    Wang, Sheng
    Yin, Na
    Li, Yingyue
    Ma, Zhaohang
    Lin, Wei
    Zhang, Lihong
    Cui, Yun
    Xia, Jianan
    Geng, Liang
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [45] Radiologic Predictors for Clinical Stage IA Lung Adenocarcinoma with Ground Glass Components: A Multi-Center Study of Long-Term Outcomes
    Li, Zhao
    Ye, Bo
    Bao, Minwei
    Xu, Binbin
    Chen, Qinyi
    Liu, Sida
    Han, Yudong
    Peng, Mingzhen
    Lin, Zhifeng
    Li, Jingpei
    Zhu, Wenzhuo
    Lin, Qiang
    Xiong, Liwen
    PLOS ONE, 2015, 10 (09):
  • [46] Predictability and Utility of Contrast-Enhanced CT on Occult Lymph Node Metastasis for Patients with Clinical Stage IA-IIA Lung Adenocarcinoma: A Double-Center Study
    Zhao, Fengnian
    Zhao, Yunqing
    Zhang, Yanyan
    Sun, Haoran
    Ye, Zhaoxiang
    Zhou, Guiming
    ACADEMIC RADIOLOGY, 2023, 30 (12) : 2870 - 2879
  • [47] Mobilization kinetics of peripheral blood stem cells with rescue plerixafor - real-world experience from a single center
    Pwint, Khaing-Shwe Wah
    Chen, Yunxin
    Diong, Colin Phipps
    Goh, Yeow-Tee
    Grant, Dixon
    Ho, Aloysius
    Hwang, William
    Kumar, Sathish
    Lee, Yuh-Shan
    Lim, Francesca
    Loh, Yvonne
    Nagarajan, Chandramouli
    Quek, Jeffrey
    Tao, Miriam
    Than, Hein
    Linn, Yeh-Ching
    LEUKEMIA & LYMPHOMA, 2020, 61 (07) : 1740 - 1743
  • [48] Efficacy and safety of surufatinib in the treatment of patients with neuroendocrine tumor: a real-world study in Chinese population
    Liu, Yuanyuan
    Yang, Xinyi
    Wang, Yan
    Xie, Songzuo
    Li, Minxing
    You, Jinqi
    Tang, Yan
    Zhao, Jingjing
    Weng, Desheng
    BMC CANCER, 2024, 24 (01)
  • [49] HotBalloon Pulmonary Vein Isolation Registry Study - Real-World Efficacy and Safety of HotBalloon Ablation -
    Yamasaki, Hiro
    Nakahara, Shiro
    Sohara, Hiroshi
    Yoshida, Yukihiko
    Kohno, Tsunesuke
    Shimane, Akira
    Miyauchi, Yasushi
    Kusano, Kengo
    Inden, Yasuya
    Yamane, Teiichi
    Aonuma, Kazutaka
    CIRCULATION JOURNAL, 2023, 87 (01) : 65 - +
  • [50] Safety of high efficacy therapies in older people with Multiple Sclerosis: A real-world evidence study
    Silva, Berenice
    Casales, Federico
    Donoso, Claudia Burbano
    Varela, Lucia
    Heriz, Alejandra
    Gonzalez, Cecilia
    Miguez, Jimena
    Alonso, Ricardo
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 90